Guangzhou Surveillance & Clinical Study in Microcephaly (GSCSM)

Status Recruiting

Clinical Trial Summary

Screening for microcephaly is important at birth and during early childhood. The Guangzhou Surveillance and Clinical Study in Microcephaly (GSCSM) aims to establish a multicentric surveillance system for microcephaly in newborns and infants, to develop a new head circumference reference and microcephaly criteria basing on the local population in Guangzhou, to improve the prediction model of microcephaly, and to follow up the outcomes of the children diagnosed with microcephaly.

Clinical Trial Description

Microcephaly is associated with neurological dysfunctions in infants and children. There is not a uniform diagnostic criteria for microcephaly. The World Health Organization (WHO) recommended a criteria of head circumference (HC) less than 2 standard deviations (SD) below the mean of the Intergrowth-21 standard, which was found not applicable to the newborns and infants in Guangzhou.In the GSCSM, the HC measures of newborns are conducted by trained midwives using a standard tool, and extensive information including adverse perinatal outcomes are collected. Longitudinal follow up of infants' neurodevelopment in cognitive, motor, emotional and other domains are also to be conducted. The GSCSM intends to find out the infants who are 'real microcephaly' and most at risk of short-term or long-term adverse outcomes in Guangzhou. ;

Study Design

Related Conditions & MeSH terms

Microcephaly

Clinical Trial Details

NCT number	NCT03651687
Study type	Observational
Source	Guangzhou Women and Children's Medical Center
Contact	Xiu Qiu, MD,PhD
Phone	0086 20 38367160
Email	qxiu0161@163.com
Status	Recruiting
Phase
Start date	February 10, 2017
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03548779` - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2	N/A
Completed	`NCT02510170` - Fetal and Maternal Head Circumference During Pregnancy in Israeli Population	N/A
Completed	`NCT01565005` - Microcephaly Genetic Deficiency in Neural Progenitors	N/A
Terminated	`NCT03922594` - Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia
Recruiting	`NCT06019182` - MEHMO Natural History and Biomarkers
Completed	`NCT02943304` - Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
Completed	`NCT03330600` - Efficacy of Aquatic Physiotherapy in Children With Microcephaly by Zika Virus Congenital Syndrome	N/A
Recruiting	`NCT03255369` - Vertical Exposure to Zika Virus and Its Consequences for Child Neurodevelopment (ZIKVIRUSIFF)
Recruiting	`NCT03325946` - The FBRI VTC Neuromotor Research Clinic
Completed	`NCT02741882` - Zika and Microcephaly: Case-control Study	N/A
Recruiting	`NCT05518188` - Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)	Phase 1/Phase 2
Completed	`NCT00001639` - Evaluation of Patients With Unresolved Chromosome Abnormalities	N/A
Withdrawn	`NCT01151462` - Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.
Completed	`NCT05322980` - Summary of Infants Weighing 500 Grams or Less
Completed	`NCT04816175` - Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay	N/A